[1]
“Rationality of Anti-Inflammatory Therapy and Determinants of Adverse Drug Reactions in Osteoarthritis Patients: A Clinical Pharmacy Study in Hospital”, JFM, vol. 9, no. 1, pp. 820–829, Oct. 2026, doi: 10.35451/jfm.v9i1.3891.